NCT04645004View on ClinicalTrials.gov

Antenatal Platelet Response on Aspirin: a Pharmacokinetic Study Through Pregnancy

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 29, 2020

Primary Completion Date

January 11, 2024

Study Completion Date

March 15, 2024

Conditions
Preeclampsia
Interventions
DRUG

Aspirin 81Mg Non-enteric coated Tab

one tab daily

Trial Locations (1)

19107

Thomas Jefferson University Hospital, Philadelphia

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

collaborator

March of Dimes

OTHER

lead

Thomas Jefferson University

OTHER

NCT04645004 - Antenatal Platelet Response on Aspirin: a Pharmacokinetic Study Through Pregnancy | Biotech Hunter | Biotech Hunter